Alphatec Holdings Hits Day High with 7.5% Surge in Stock Price

Alphatec Holdings, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable surge today, gaining 7.5% and reaching an intraday high of USD 9.42. This performance stands in stark contrast to the S&P 500, which saw a modest increase of just 0.21% on the same day. Over the past week, Alphatec has shown a robust performance with a 12.29% increase, while the S&P 500 declined by 1.07%. However, the company's longer-term performance reveals a more complex picture. Over the past year, Alphatec's stock has decreased by 16.71%, significantly underperforming the S&P 500, which gained 16.26%. Year-to-date, the stock has faced a steep decline of 55.7%. Despite today's gains, Alphatec Holdings is grappling with operational challenges, including high debt levels and a negative return on equity of -283.77%. The company's debt-to-EBITDA ratio stands at 23.26 times, indicating potential difficulties in servicing its debt. As it navigates these financial metrics, Alphatec's market position remains under scrutiny.